Meyer-Olson D, Hoeper K, Hammel L, Lieb S, Haehle A, Kiltz U
Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.
Rheumatologie und Immunologie, m&i Fachklinik Bad Pyrmont/MVZ Weserbergland, Bad Pyrmont, Deutschland.
Z Rheumatol. 2024 Aug;83(6):500-509. doi: 10.1007/s00393-023-01410-w. Epub 2023 Sep 19.
The treatment of axial spondylarthritis (axSpA) includes pharmacological treatment measures (PTM) and nonpharmacological treatment measures (NPTM) as well as supporting resources, such as rehabilitation services (RS) and membership in patient support groups (PSG). Nevertheless, there are significant participation restrictions in patients with axSpA in Germany.
Investigation of functional deficits, participation restrictions and utilization of PTM, NPTM, RS and PSG membership in patients with axSpA.
Multicentric, observational study of 770 axSpA patients in Germany (ATTENTUS-axSpA).
Substantial functional deficits and participation restrictions were observed in axSpA patients. Of the patients 39% did not receive treatment with biological disease-modifying antirheumatic drugs (bDMARD). In the NPTM 54% received physiotherapy less than once per week and 29% once per week. Physical activities were regularly performed by 86% of patients, mainly in the form of home exercises. Training in a gym (14%) or sports club (7%) was carried out much less frequently. Of the patients 54% received RS, one third had the last rehabilitation more than 5 years ago and 13% of the patients were members in a PSG. A significantly higher utilization of NPTM and rehabilitation was found in this group.
Treatment options and resources were often utilized to a small extent and/or in low intensity by axSpA patients, which could be a possible explanation for persisting restrictions of participation. Membership in a PSG was associated with an increased utilization of NPTM and RS.
中轴型脊柱关节炎(axSpA)的治疗包括药物治疗措施(PTM)和非药物治疗措施(NPTM)以及辅助资源,如康复服务(RS)和患者支持小组(PSG)成员资格。然而,德国axSpA患者存在显著的参与限制。
调查axSpA患者的功能缺陷、参与限制以及PTM、NPTM、RS和PSG成员资格的利用情况。
对德国770例axSpA患者进行多中心观察性研究(ATTENTUS-axSpA)。
观察到axSpA患者存在严重的功能缺陷和参与限制。39%的患者未接受生物改善病情抗风湿药物(bDMARD)治疗。在NPTM中,54%的患者每周接受物理治疗少于一次,29%的患者每周接受一次。86%的患者定期进行体育活动,主要形式为家庭锻炼。在健身房(14%)或体育俱乐部(7%)进行训练的频率要低得多。54%的患者接受了RS,三分之一的患者最后一次康复是在5年多以前,13%的患者是PSG成员。该组患者对NPTM和康复的利用率显著更高。
axSpA患者对治疗选择和资源的利用程度往往较低和/或强度较低,这可能是参与持续受限原因的一种解释。PSG成员资格与NPTM和RS利用率的提高有关。